Seven 2020 Democratic presidential candidates want to make the abortion drugs misoprostol and mifepristone available without a prescription.
The New York Times interrogates Democratic presidential candidates on whether they would “make misoprostol and mifepristone available without a prescription.” Of the 16 candidates included in the survey, seven said they would make abortion drugs available over the counter.
2020 candidates Michael Bennet, Cory Booker, Pete Buttigieg, Tom Steyer, Elizabeth Warren, Marianne Williamson and Andrew Yang each answered “yes”, while former Vice President Joe Biden did not answer the question and the 2020 candidates Kamala Harris, Bernie Sanders, Julian Castro. and Tulsi Gabbard’s position on the issue is “unclear”, according to the Times. The publication conducted the survey before 2020 Democrats Michael Bloomberg and Deval Patrick entered the race.
Misoprostol and mifepristone are two drugs used in an “abortion pill” to “terminate a pregnancy”. according to Planned Parenthood’s page on “The Abortion Pill.” (RELATED: Here are Democratic candidates who want to ban abstinence-only sex ed as president)
“Mifepristone blocks your body’s progesterone, preventing pregnancy from developing,” says Planned Parenthood. “Then you take the second drug, misoprostol, either right away or up to 48 hours later. This medication causes cramping and bleeding to drain your uterus. It’s a bit like having a very heavy cramping period, and the process is very similar to an early miscarriage.
Planned Parenthood notes that the abortion pill is “very effective,” adding that the abortion pill works about 94-98 times out of 100 for pregnant mothers 8 weeks or less, 94-96 times out of 100 for mothers 8-9 weeks. pregnancy and 91-93 times out of 100 for mothers 9-10 weeks pregnant. The effectiveness of the pill decreases depending on the progress of the mother’s pregnancy.
Bennet added in the survey that he supports making abortion drugs available over-the-counter with “optional pharmacist consultation,” while Buttigieg suggests ignoring the Risk Assessment and Mitigation Strategy (REMS). ) applied to mifepristone. REMS is a Food and Drug Administration (FDA) drug safety program that the FDA requires “for certain drugs with serious safety concerns.”
Planned Parenthood and other abortion advocates have called for removing REMS from mifepristone, but the FDA warns that buyers “should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your (and others’) health”.
As of December 31, 2018, there were 24 deaths women who have been associated with the abortion drug since it was first approved in September 2000, according to the FDA.
The FDA notes that although it has received reports of serious adverse events in cases where women were taking abortion-inducing drugs, “adverse events cannot with certainty be causally attributed to mifepristone due to concurrent use of other medications, other medical or surgical treatments, existing medical conditions and gaps in information about the patient’s medical condition and clinical management of the patient.
Susan B. Anthony List, vice president of communications, Mallory Quigley, said the candidates’ positions on abortive drugs should come as no surprise.
“It’s no surprise that leading Democratic presidential candidates support the unfettered expansion of dangerous abortion drugs into the hands of vulnerable women and girls,” Quigley told the Daily Caller News Foundation.
“Overall, they are extremists who support abortion on demand up to birth, paid for by taxpayers, and even infanticide,” Quigley added. “Their radical program is at odds with the american people and will be a political handicap in 2020.”
Editor’s Note: This story has been updated to include clarifying language that the FDA could not with certainty attribute causation of adverse events to mifepristone.
Content created by the Daily Caller News Foundation is available at no cost to any eligible news publisher who can provide a large audience. For licensing opportunities of our original content, please contact [email protected]